Cardlytics Inc (CDLX) Stock: A Value Analysis

Moreover, the 36-month beta value for CDLX is 1.47. Analysts have varying opinions on the stock, with 4 analysts rating it as a “buy,” 1 as “overweight,” 1 as “hold,” and 0 as “sell.”

The public float for CDLX is 40.76M and currently, short sellers hold a 11.00% of that float. On April 03, 2024, CDLX’s average trading volume was 1.67M shares.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

CDLX) stock’s latest price update

The stock of Cardlytics Inc (NASDAQ: CDLX) has decreased by -5.60 when compared to last closing price of 14.46. Despite this, the company has experienced a -32.59% fall in its stock price over the last five trading sessions. The Motley Fool reported 2024-04-02 that Cardlytics stock skyrocketed because its business showed improved trends. The company then refinanced some of its debt at a higher rate, which troubled investors.

CDLX’s Market Performance

CDLX’s stock has fallen by -32.59% in the past week, with a monthly rise of 62.69% and a quarterly rise of 48.21%. The volatility ratio for the week is 15.04% while the volatility levels for the last 30 days are 11.95% for Cardlytics Inc The simple moving average for the last 20 days is 15.47% for CDLX stock, with a simple moving average of 32.38% for the last 200 days.

Analysts’ Opinion of CDLX

Many brokerage firms have already submitted their reports for CDLX stocks, with Craig Hallum repeating the rating for CDLX by listing it as a “Buy.” The predicted price for CDLX in the upcoming period, according to Craig Hallum is $18 based on the research report published on March 15, 2024 of the current year 2024.

Lake Street, on the other hand, stated in their research note that they expect to see CDLX reach a price target of $13. The rating they have provided for CDLX stocks is “Buy” according to the report published on November 29th, 2023.

Wells Fargo gave a rating of “Underweight” to CDLX, setting the target price at $13 in the report published on September 08th of the previous year.

CDLX Trading at 53.81% from the 50-Day Moving Average

After a stumble in the market that brought CDLX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -33.48% of loss for the given period.

Volatility was left at 11.95%, however, over the last 30 days, the volatility rate increased by 15.04%, as shares surge +77.97% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +121.23% upper at present.

During the last 5 trading sessions, CDLX fell by -32.59%, which changed the moving average for the period of 200-days by +139.05% in comparison to the 20-day moving average, which settled at $12.12. In addition, Cardlytics Inc saw 48.21% in overturn over a single year, with a tendency to cut further gains.

Insider Trading

Reports are indicating that there were more than several insider trading activities at CDLX starting from Temsamani Karim Saad, who sale 32,564 shares at the price of $13.69 back on Apr 02 ’24. After this action, Temsamani Karim Saad now owns 344,734 shares of Cardlytics Inc, valued at $445,801 using the latest closing price.

Lynton Nicholas Hollmeyer, the Chief Legal & Privacy Officer of Cardlytics Inc, sale 12,460 shares at $13.69 during a trade that took place back on Apr 02 ’24, which means that Lynton Nicholas Hollmeyer is holding 71,355 shares at $170,620 based on the most recent closing price.

Stock Fundamentals for CDLX

Current profitability levels for the company are sitting at:

  • -0.28 for the present operating margin
  • 0.43 for the gross margin

The net margin for Cardlytics Inc stands at -0.37. The total capital return value is set at -0.22. Equity return is now at value -77.77, with -21.29 for asset returns.

Based on Cardlytics Inc (CDLX), the company’s capital structure generated 0.66 points at debt to capital in total, while cash flow to debt ratio is standing at -0.0. The debt to equity ratio resting at 1.93. The interest coverage ratio of the stock is -14.32.

Currently, EBITDA for the company is -34.15 million with net debt to EBITDA at -4.0. When we switch over and look at the enterprise to sales, we see a ratio of 2.48. The receivables turnover for the company is 2.48for trailing twelve months and the total asset turnover is 0.54. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.31.


To wrap up, the performance of Cardlytics Inc (CDLX) has been better in recent times. The stock has received a bullish of “buy” and “hold” ratings from analysts. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.

Related Posts